We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serum and Synovial Uric Acid Validated as Markers for Osteoarthritis

By LabMedica International staff writers
Posted on 02 Feb 2011
Print article
The amount of uric acid in the synovial fluid of the knee is strongly correlated with the severity of osteoarthritis and the progression of the disease over time.

The amount of uric acid in both serum and synovial fluid can be estimated using high performance liquid chromatography (HPLC) and correlated with the severity of debilitating joint degeneration found in patients with osteoarthritis (OA).

A study carried out at Duke University Medical Center (Durham, NC, USA) examined 159 (118 females, 41 males) patients, who had knee osteoarthritis but no history of gout, a type of arthritis triggered by uric acid crystals in the joints. A total of 138 participants returned for follow-up three years later to assess progression of knee OA. The study was conducted from January 2003 until March 2008. Serum and knee synovial fluid samples were obtained within 10 minutes of each other after a two hour fast in the mid-afternoon. The synovial fluid analyses were limited to 69 study participants (49 women and 20 men) with sufficient synovial fluid volumes for uric acid analyses.

Although this cohort was recruited based on knee OA and absence of gout history, a surprising 39% of this cohort had serum uric acid concentrations above their respective reference ranges of 7.2 mg/dL for men and 6.0 mg/dL for women. Uric acid was quantified in both knees of 63 participants and single knees of 6 participants, and their paired sera. The mean serum uric acid concentrations were significantly higher than their paired synovial fluid uric acid concentrations. Of the 132 synovial fluid samples, matched serum exceeded synovial fluid uric acid concentrations for 113 (85.6%), whereas only 19 (14.4%) had greater synovial fluid than serum uric acid concentrations.

Virginia Byers Kraus, MD, PhD, professor of medicine at Duke University, said, "We've always thought of uric acid as the agent for gout, but it may be a much more general agent. In a non-gout population, this provides some of the very first evidence that uric acid level is a potential cause of inflammatory events and joint degeneration in osteoarthritis.” The study was accepted for publication on December 10, 2010, in the Proceeding of the [US] National Academy of Science of the United States, (PNAS).

Related Links:

Duke University Medical Center



Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System
New
Ureaplasma Urealyticum Test
Duplicα RealTime Ureaplasma Urealyticum Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.